PlainPharmaWatch

CMS Open Payments · Program Year 2024

Janssen Biotech, Inc.

Janssen Biotech, Inc. reported $31,512,537.85 in payments to 298,174 physicians and teaching hospitals across 298,176 transactions.

See the rankings → How this is sourced
$31.5M
Total payments
298,176
Transactions
298,174
Recipients
+$7.8M
General Payments vs PY2023

Janssen Biotech, Inc. reported $31,512,537.85 in payments to 298,174 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #67 of 1,925 reporting manufacturers (0.2% of all US industry payments), averaging $105.69 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Janssen Biotech, Inc. pairs top-5% payment volume with an unusually diversified payment pattern across a wide recipient base.

#67
of 1,925 companies
0.2%
of all US industry payments
0.0%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Janssen Biotech, Inc.'s CMS-reported General Payments increased by $7.8M (+33.7%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: JANSSEN BIOTECH, INC.PY2023: JANSSEN BIOTECH, INC.PY2024: Janssen Biotech, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$23.1MPY2024$30.9M
PY2023
$23,113,450.63
PY2024
$30,912,537.85

How Janssen Biotech, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Janssen Biotech, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$31,512,538 Top 3% higher than 97% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). This entry sits in this band. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Janssen Biotech, Inc.

Rank #67 of 1,925 companies in CMS Open Payments for 2024 belongs to Janssen Biotech, Inc., which reported $31,512,537.85 across 298,176 transactions to 298,174 recipients - representing 0.2% of all industry payments reported nationwide for the year. Averages work out to $105.68 per transaction and $105.69 per recipient.

Of the 7 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $17.0M across 5,942 transactions, 53.8% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Janssen Biotech, Inc.'s 7-category general-payment breakdown at $17.0M, 53.8% of the reported total.

How Janssen Biotech, Inc. divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$17.0M2. Food and Beverage$6.6M3. Consulting Fee$3.0M4. Travel and Lodging$2.9M5. Education$1.0M6. Space Rental or Facility …$327.6K7. Charitable Contribution$10.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $17.0M 5,942
Food and Beverage $6.6M 270,943
Consulting Fee $3.0M 1,304
Travel and Lodging $2.9M 7,776
Education $1.0M 12,112
Space Rental or Facility Fees $327.6K 96
Charitable Contribution $10.0K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $781,892.43 (2.5%) of $30,912,537.85 in this company's General Payments records across 49,940 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Janssen Biotech, Inc.

The five named recipients with the highest reported General Payments from this company

Cedars-Sinai Medical Center$253.5KDouglas Long Nguyen$134.3KScott B Sellinger$134.2KMaya D Srivastava$131.7KNicole Seminara$128.2K
  1. 1

    Cedars-Sinai Medical Center

    $253,500.00 across 7 reported transactions

  2. 2

    Douglas Long Nguyen

    $134,324.40 across 158 reported transactions

  3. 3

    Scott B Sellinger

    $134,193.74 across 171 reported transactions

  4. 4

    Maya D Srivastava

    $131,720.79 across 87 reported transactions

  5. 5

    Nicole Seminara

    $128,153.50 across 127 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $105.68. Average per recipient: $105.69.

Total Amount

$31,512,537.85

Avg per Transaction

$105.68

Avg per Recipient

$105.69

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Janssen Biotech, Inc. Share

0.2%

#67 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Janssen Biotech, Inc.

Medical Device Business Services, Inc.

$31.1M 32,296 recipients

Eisai Inc.

$31.1M 50,482 recipients

Novo Nordisk Inc

$30.9M 495,369 recipients

Chiesi USA, Inc.

$30.8M 9,915 recipients

Novavax Inc

$30.4M 104 recipients

Allerderm Laboratories

$32.7M 5 recipients

Frequently Asked Questions

How much did Janssen Biotech, Inc. pay to physicians and hospitals in 2024? ▾
0.2% of all industry payments reported to CMS Open Payments for 2024 came from Janssen Biotech, Inc., totaling $31,512,537.85 across 298,176 transactions to physicians and hospitals.
How many physicians received payments from Janssen Biotech, Inc.? ▾
Averaging $105.69 per recipient, Janssen Biotech, Inc.'s 2024 payments reached 298,174 physicians and teaching hospitals.
What types of payments did Janssen Biotech, Inc. make? ▾
Janssen Biotech, Inc. made 7 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Compensation for Services Other Than Consulting" at $17.0M, representing 53.8% of the company's reported total.
How does Janssen Biotech, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Janssen Biotech, Inc. ranks #67 by total payment amount.
What is the average payment size from Janssen Biotech, Inc.? ▾
In 2024, Janssen Biotech, Inc. averaged $105.68 per transaction across 298,176 transactions to 298,174 recipients.
Where does the payment data for Janssen Biotech, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Janssen Biotech, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.